Statutory Rules 1993   No. 2701

__________________

Health Insurance (1993-1994 Pathology Services Table) Regulations

__________________

TABLE OF PROVISIONS

Regulation  Page

1. Commencement 1

2. Citation 1

3. Repeal of Health Insurance (1992-1993 Pathology Services Table) Regulations              2

4. Pathology services table 2

 SCHEDULE 

 TABLE OF PATHOLOGY SERVICES 3

PART 1—RULES OF INTERPRETATION 3

PART 2—SERVICES AND FEES 13

PART 3—ABBREVIATIONS 37

Statutory Rules 1993   No. 2701

__________________

Health Insurance (1993-1994 Pathology Services Table) Regulations

I, The Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Health Insurance Act 1973.

Dated 28 October 1993.

 BILL HAYDEN

 Governor-General

By His Excellency’s Command,

GRAHAM RICHARDSON

Minister for Health

____________

Commencement

 1. These Regulations commence on 1 November 1993.

Citation

 2. These Regulations may be cited as the Health Insurance (1993-1994 Pathology Services Table) Regulations.

Repeal of Health Insurance (1992-1993 Pathology Services Table) Regulations

 3. Statutory Rules 1992 No. 336 and 1993 No. 125 are repealed.

Pathology services table

 4. The table of pathology services in the Schedule is prescribed for the purposes of subsection 4a (2) of the Health Insurance Act 1973.

 SCHEDULE Regulation 4

TABLE OF PATHOLOGY SERVICES

PART 1—RULES OF INTERPRETATION

 1. (1) In this table, unless the contrary intention appears:

“approved pathology authority” has the same meaning as in Division 4A of Part IIa of the Act;

“patient episode” means:

 (a) a pathology service to which rule 3a refers that is provided in the circumstances described in that rule that relate to the service; and

 (b) except in the case of a pathology service to which paragraph (a) refers—a pathology service or pathology services, whether specified in a single item or in more than 1 item, provided for a single patient whose need for the service or services was determined under subsection 16a (1) of the Act on the same day, whether rendered by an approved pathology practitioner or more than 1 approved pathology practitioner on the same day or on different days;

“recognised pathologist” means a medical practitioner recognised as a specialist in pathology by a determination under subsection 61 (3) of the Act;

“the Act” means the Health Insurance Act 1973.

 (2) In these Rules, a reference to a request to an approved pathology practitioner includes a reference to a request for a pathologist-determinable service to which subsection 16a (6) of the Act applies.

 (3) Unless the contrary intention appears, a reference in this table by number to an item that is not included in this table is a reference to the correspondingly numbered item in the general medical services table or the diagnostic imaging services table, as each case requires.

 2. (1) If a service is described:

 (a) in an item in general terms; and

 (b) in another item in specific terms:

only the item that describes the service in specific terms applies to the service.

 (2) Subject to subrule (3), if:

 (a) a service is described in 2 or more items; and

 (b) subrule (1) does not apply;

only the item that provides the lower or lowest fee for the service applies to the service.

 (3) If an item is expressed to include a pathology service that is specified in another item, the other item does not apply to the service in addition to the first-mentioned item.

 3. (1) In subrule (2), “service” includes assay, estimation and test.

 (2) Subject to rule 3a, 2 or more pathology services rendered for a patient following 2 or more requests are taken to have been rendered following a single request if:

 (a) the services are listed in the same item; and

 (b) the patient’s need for the services was determined under subsection 16a (1) of the Act on the same day even if they are rendered by an approved pathology practitioner on more than one day.

 3a. (1) Rule 3 does not apply to:

 (a) a pathology service specified in item 66201, other than an estimation of fructosamine or lithium; or

 (b) the quantitative estimation of 1 or more fractions of neonatal bilirubin specified in item 66365;

if:

 (c) the service is rendered in relation to a single specimen taken on each of not more than 4 occasions in a period of 24 hours; and

 (d) the service is rendered to a patient in a hospital unit where:

 (i) the presence of 1 nurse is required for each group of not more than 4 patients; and

 (ii) the condition of the patients is continuously observed in relevant respects; and

 (e) in order to render the service, an approved pathology practitioner who is a recognised pathologist has to arrange for a member of the laboratory staff of the approved pathology authority concerned to undertake duties in respect of the service that are in addition to the usual duties of the staff member.

 (2) Rule 3 does not apply to any of the following pathology services if, under a request for a service, no more than 6 tests are requested and the tests are performed within 6 months of the request:

 (a) estimation of prothrombin time in respect of a patient undergoing anticoagulant therapy;

 (b) quantitative estimation of lithium in respect of a patient undergoing lithium therapy;

 (c) a service specified in item 65007 in relation to a patient undergoing chemotherapy for neoplastic disease or immunosuppressant therapy;

 (d) a service specified in item 65007 in relation to methotrexate, gold or penicillamine therapy of a patient;

 (e) a service specified in item 66201 in relation to methotrexate therapy of a patient;

 (f) quantitative estimation of urea, creatinine and electrolytes in relation to:

 (i) cis-platinum therapy of a patient; or

 (ii) chronic renal failure of a patient being treated in a dialysis program conducted by a recognised hospital.

 (2a) Rule 3 does not apply to a pathology service:

 (a) to which item 66217 applies; and

 (b) for which a specimen is collected on each of 3 days for the purpose of making a valid estimation.

 (3) This rule does not apply in relation to a pathology service unless the account for fees in respect of the service is endorsed with the words “Rule 3 Exemption”.

 4. If:

 (a) a pathology service to which an item of the table applies is rendered for a patient in accordance with a request; and

 (b) another pathology service is rendered for the patient in accordance with the request; and

 (c) an item of the table:

 (i) applies to the other service; and

 (ii) is referred to in the item mentioned in paragraph (a);

the other service is treated as if it were part of the service referred to in paragraph (a).

  Example:

  The requesting practitioner requests an extended blood grouping test (covered by item 65019) and the test includes a basic blood grouping test (covered by item 65017). Item 65017 is referred to in item 65019. Benefit is payable under item 65019 for the extended blood grouping test but benefit is not payable separately under item 65017 for the basic blood grouping test.

 5. For the purposes of items 65001 to 66200 (inclusive):

 (a) if pathology services of a kind referred to in item 65017 or 65019 are rendered for a patient during a period when the patient is in hospital, the item applies only to the first pathology service of that kind rendered for the patient during that period; and

 (b) tests (except the tests mentioned in item 65023) carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

 5a. (1) In this rule:

“designated pathology service” means a pathology service specified in item 66241, 66389, 66403 or 69241.

 (2) Subject to subrule (3), if an approved pathology practitioner in an approved pathology authority:

 (a) has been requested to render a pathology service that specified 2 or more estimations comprising a designated pathology service; and

 (b) is unable to perform 1 or more, but not all, of the estimations because of the lack of facilities in, or expertise or experience of the staff of, the laboratory of the authority in relation to that estimation or those estimations; and

 (c) requests an approved pathology practitioner in another approved pathology authority to render 1 or more, but not all, of the estimations;

the service rendered by the second-mentioned practitioner is taken to be the designated pathology service.

 (3) Items 73901 to 73917 (inclusive) do not apply to the second-mentioned approved pathology practitioner in subrule (2).

 6. For the purposes of items 66201 to 69200 (inclusive):

 (a) if a pathology service involving the measurement of a substance in urine requires a 24 hour urine collection, or calculation of a substance/creatinine ratio, the service is treated as including any estimation of creatinine in other fluids necessary for the calculation; and

 (b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

 7. For the purposes of items 69201 to 71000 (inclusive):

 (a) “serial examinations or cultures” means examinations or cultures requested on 1 occasion whether or not;

 (i) the materials are received on different days by the approved pathology practitioner; or

 (ii) the examinations or cultures were requested on 1 or more request forms by the treating practitioner; and

 (b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

 8. For the purposes of items 71001 to 72800 (inclusive):

 (a) in items 71119, 71121, 71123 and 71125, the estimation of a single antibody includes qualitative and quantitative assays for that antibody; and

 (b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

 9. For the purposes of items 72801 to 73040 (inclusive):

 (a) “biopsy material” means all tissue received by the approved pathology practitioner from an operation, or a group of operations, performed on a patient at the same time, other than a bone marrow biopsy; and

 (b) if:

 (i) a pathology service that is the examination of biopsy material is rendered under any of those items; and

 (ii) a further pathology service mentioned in any of those items is also rendered using that biopsy material;

  those pathology services are treated as 1 pathology service.

 10. For the purposes of items 73041 to 73280 (inclusive), “serial examinations” means examinations requested on 1 occasion whether or not:

 (a) the materials are received on different days by the approved pathology practitioner; or

 (b) the examinations were requested on 1 or more request forms by the treating practitioner.

 11. (1) For the purposes of this rule and items 73901 to 73921 (inclusive):

“institution” means a place (other than a hospital, a nursing home or accommodation for aged persons that is attached to a nursing home or situated within a nursing home complex) at which residential accommodation or day care is, or both residential accommodation and day care are, made available to:

 (a) disadvantaged children; or

 (b) juvenile offenders; or

 (c) aged persons; or

 (d) chronically ill psychiatric patients; or

 (e) homeless persons; or

 (f) unemployed persons; or

 (g) persons suffering from alcoholism; or

 (h) persons addicted to drugs; or

 (i) physically or mentally handicapped persons;

“licensed collection centre” has the same meaning as in Part IIa of the Act;

“prescribed laboratory” means a laboratory operated by:

 (a) the Commonwealth; or

 (b) a State; or

 (c) an authority of a State or Territory; or

 (d) the Northern Territory; or

 (e) the Australian Capital Territory; or

 (f) an Australian tertiary education institution.

“specimen collection centre” has the same meaning as in Part IIa of the Act;

“temporary collection centre” has the same meaning as in Part IIa of the Act;

“treating practitioner” has the same meaning as in paragraph 16a (1) (a) of the Act.

 (2) A service mentioned in items 73901 to 73921 (inclusive) applies to a pathology service when rendered by, or on behalf of, an approved pathology practitioner who is a recognised pathologist unless:

 (a) the service is rendered upon a request made in the course of an out-patient service at a recognised hospital; or

 (b) the service is rendered upon a request made for a patient who is a private patient in a recognised hospital when the request was made; or

 (c) the pathology equipment of a recognised hospital, or prescribed laboratory, is used rendering the service; or

 (d) a member of the staff of a recognised hospital, or prescribed laboratory, participates in the service in the course of the member’s employment with the hospital or laboratory.

 (3) A service mentioned in items 73901 to 73921 (inclusive) does not apply to a pathology service:

 (a) to which subsection 16a (7) of the Act applies; or

 (b) unless at least one of items 65001 to 73529 (inclusive) also applies to that service.

 (4) Subject to subrule (6), if one item of items 73901 to 73917 (inclusive) applies to a patient episode, none of the remainder of those items applies to that patient episode.

 (5) Item 73921 applies only to the approved pathology practitioner or approved pathology authority to whom the specimen mentioned in the item was referred.

 (6) If, in respect of the same patient episode:

 (a) services referred to in 1 or more items:

 (i) in Group P5; and

 (ii) in one of Groups P1, P2, P3, P4, P6, P7 and P8; or

 (b) services referred to in 1 or more items:

 (i) in Group P6; and

 (ii) in one of Groups P1, P2, P3, P4, P5, P7 and P8;

are rendered by an approved pathology practitioner in each of 2 approved pathology authorities, the applicable amount specified in an item in Group P10 is payable to both approved pathology practitioners.

 (7) If more than one specimen is collected from a person on the same day for the provision of pathology services:

 (a) in accordance with more than one request; and

 (b) in or by a single approved pathology authority;

only a single amount specified in the applicable item in Group P10 is payable for the services.

 11a. If item 73921 applies to a patient episode, none of items 73901 to 73917 (inclusive) applies to any pathology service rendered by the approved pathology authority or the approved pathology provider in respect of that patient episode.

 11b. (1) Item 73921 does not apply to a referral if:

 (a) a service in respect of the same patient episode has been carried out by the referring approved pathology authority; and

 (b) the approved pathology authority to which the referral is made is related to the referring approved pathology authority.

 (2) An approved pathology authority is related to another approved pathology authority for the purposes of subclause (1) if:

 (a) both approved pathology authorities are employed (including employed under contract) by the same person, whether or not that person is also an approved pathology authority; or

 (b) either of the approved pathology authorities is employed (including employed under contract) by the other; or

 (c) if both of the approved pathology authorities are corporations—the approved pathology authorities are related corporations within the meaning of the Corporations Law; or

 (d) the approved pathology authorities are partners (whether or not either or both of the approved pathology authorities are individuals and whether or not other persons are in partnership with either or both of the approved pathology authorities).

 12. The abbreviations in Part 3 of this table may be used to identify particular pathology services or groups of pathology services.

SCHEDULE—continued

PART 2—SERVICES AND FEES

GROUP P1—HAEMATOLOGY

GROUP P2—CHEMICAL

GROUP P3—MICROBIOLOGY

GROUP P4—IMMUNOLOGY

GROUP P5—HISTOPATHOLOGY

GROUP P6—CYTOPATHOLOGY

GROUP P7—CYTOGENETICS

GROUP P8—INFERTILITY AND PREGNANCY TESTS

GROUP P9—SIMPLE BASIC PATHOLOGY TESTS

GROUP P10—PATIENT EPISODE INITIATION

GROUP P11—SPECIMEN REFERRED

PART 3—ABBREVIATIONS

A—ABBREVIATIONS FOR GROUPS OF TESTS

B—ABBREVIATIONS FOR INDIVIDUAL TESTS

Abnormal haemoglobins AH 65027

Acetoacetate ACAT 66367

Acetylcholine receptor—tissue antigens—antibodies ARA 71109

Actinomycetes—microbial antibody testing ACT 69229

Adenovirus—microbial antibody testing ADE 69229

Adrenal cortex—tissue antigens—antibodies ADR 71109

Adrenocorticotrophic hormone (ACTH) ACTH 66391

AFB microscopy and culture of sputum AFB 69213

Alanine aminotransferase ALT 66201

Albumin ALB 66201

Alcohol (ethanol) ETOH 66367

Aldosterone ALDS 66391

Alkaline phosphatase ALP 66201

Alkaline phosphatase—isoenzymes ALPI 66245

Alpha fetoprotein AFP 66353

Alpha fetoprotein—for Down syndrome/neural tube defect testing NTDD 66321

Alpha‑1‑acid glycoprotein AAG 66255

Alpha-1-antitrypsin AAT 66255

Alpha‑2‑macroglobulin AMG 66255

Aluminium AL 66277

Aluminium—renal dialysis ALR 66325

Amino acids AA 66367

Amiodarone AMIO 66235

Amitriptyline AMIT 66235

Ammonia NH3 66367

Amniotic fluid examination AFE 66243

Amylase AMS 66201

Amylobarb AMYL 66235

Androstenedione ANDR 66377

Angiotensin converting enzyme ACE 66367

Antibiotic and antimicrobial chemotherapeutic agents—quantitative assay QAA 69251

Antibodies to—extractable nuclear antigens—detection ENA 71101

Antibodies to—extractable nuclear antigens—characterisation of antibodies if positive ENA ENAP              71103

Antibodies to—nuclear antigens—detection ANA 71097

Antibodies to—nuclear antigens—quantitation and measurement of DNA binding if positive ANA ANAP              71099

Antibodies to—tissue antigens—acetylcholine receptor ARA 71109

Antibodies to—tissue antigens—adrenal cortex ADR 71109

Antibodies to—tissue antigens—cardiolipin ACL 71109

Antibodies to—tissue antigens—centromere ACA 71119

Antibodies to—tissue antigens—gastric parietal cell PCA 71119

Antibodies to—tissue antigens—gliadin IgA GLIA 71119

Antibodies to—tissue antigens—glomerular basement membrane GBA 71109

Antibodies to—tissue antigens—heart AHE 71109

Antibodies to—tissue antigens—histone AHI 71109

Antibodies to—tissue antigens—insulin receptor antibodiesINSA 71109

Antibodies to—tissue antigens—intercellular cement substance of skin ICCS 71109

Antibodies to—tissue antigens—intrinsic factor AIF 71109

Antibodies to—tissue antigens—islet cell AIC 71109

Antibodies to—tissue antigens—Jo‑1 JO1 71119

Antibodies to—tissue antigens—keratin KERA 71119

Antibodies to—tissue antigens—liver/kidney microsomes LKA 71119

Antibodies to—tissue antigens—lymphocyte ALY 71109

Antibodies to—tissue antigens—mitochondria MA 71119

Antibodies to—tissue antigens—neuron ANE 71109

Antibodies to—tissue antigens—neutrophil cytoplasm ANCA 71109

Antibodies to—tissue antigens—ovary AOV 71109

Antibodies to—tissue antigens—parathyroid PTHA 71109

Antibodies to—tissue antigens—platelet APA 71109

Antibodies to—tissue antigens—PM‑Sc1 PM1 71119

Antibodies to—tissue antigens—reticulin RCA 71119

Antibodies to—tissue antigens—salivary gland ASG 71109

Antibodies to—tissue antigens—Scl‑70 SCL 71119

Antibodies to—tissue antigens—skeletal muscle SLA 71109

Antibodies to—tissue antigens—skin basement membrane SKA 71109

Antibodies to—tissue antigens—smooth muscle SMA 71119

Antibodies to—tissue antigens—thyroglobulin ATG 71109

Antibodies to—tissue antigens—thyroid microsome TMA 71109

Antibodies to—tissue antigens—TSH receptor antibody testTSHA 71109

Antibody testing, microbial (See Microbial)

Antigen testing, microbial (See Microbial)

Antithrombin III ATH 65037

Anus—cytology on specimens from SMCY 73043

Apolipoprotein B/A1 ratio APO 66317

Arginine infusion ARIN 66297

Arsenic AS 66277

Aspartate aminotransferase AST 66201

Aspergillus—microbial antibody testing ASP 69229

Avian precipitins (bird fancier’s disease)—microbial antibody testing APP 69229

B12 vitamin RCF 66267

Barbiturate BARB 66235

Beryllium BE 66277

Beta‑hydroxybutyrate BHYB 66367

Beta‑2‑microglobulin BMIC 66361

Bicarbonate HCO3 66201

Bilirubin (all fractions) BILI 66201

Bilirubin (all fractions)—in urine UBIL 66213

Bilirubin (all fractions)—neonatal BILN 66365

Bird fancier’s disease (Avian precipitins)—microbial antibody testing APP 69229

Blastomyces—microbial antibody testing BLM 69229

Bleeding time BT 65029

Blood—compatibility testing XMAT 65023

Blood—culture BC 69215

Blood—film BF 65005

Blood—full examination FBE 65001

Blood—gases GAS 66225

Blood—group and blood group antibodies BGAB 65021

Blood—group antibodies BGA 65025

Blood—group systems BGS 65019

Blood—grouping‑ABO and RH (D antigen) BG 65017

Blood—viscosity VISC 65001

Body cavities—aspirations of—microscopy and culture of material from MCS3 69209

Body fluids—cytology BFCY 73045

Bone marrow examination—aspirate BMEA 65015

Bone marrow examination—trephine BMET 65013

Bordetella pertussis—microbial antibody testing BOR 69229

Borrelia burgdorferi—microbial antibody testing BOB 69229

Breath hydrogen test BHT 66283

Bromide BRMD 66235

Brucella—microbial antibody testing BRU 69229

C‑l esterase inhibitor—quantitative CEIQ 66257

C‑l esterase inhibitor—functional CEIF 66258

C‑Peptide CPEP 66391

C‑reactive protein CRP 65001

CA‑15.3 antigen CA15 66261

CA‑l9.9 antigen CA19 66261

CA‑125 antigen C125 66261

Cadmium CD 66277

Caeruloplasmin CPLS 66361

Calcitonin CALT 66391

Calcium (total, dialysed or ionized) CA 66201

Calculus analysis CALC 66229

Campylobacter jejuni—microbial antibody testing CAM 69229

Candida—microbial antibody testing CAN 69229

Carbamazepine (Tegretol) CARB 66235

Carboxyhaemoglobin COHB 65027

Carcinoembryonic antigen CEA 66261

Cardiac enzymes (see group tests) CE 66205

Cardiolipin—tissue antigens—antibodies ACL 71109

Catecholamines CAT 66281

Cell mediated immunity—delayed type—hypersensitivity testCMI 71137

Centromere—tissue antigens—antibodies ACA 71119

Cervix—cytology—routine CCR 73053

Cervix—cytology—abnormalities CCRA 73055

Cervix—microscopy and culture of material from MCS2 69207

Characterisation of antibodies if positive ENA ENAP 71103

Chemicals, toxic (ingested or absorbed)—assays DRGO 66231

Chlamydia—direct detection from clinical material CHLY 69221

Chlamydia—investigation by cultural methods CHLC 69261

Chlamydia—investigation by DNA probe CHLP 69261

Chlamydia—microbial antibody testing CHL 69229

Chlamydia—microbial antigen testing CHLY 69221

Chloral hydrate CHHY 66235

Chlorazepate CHZP 66235

Chloride CL 66201

Chloroquine CLOQ 66235

Chlorpromazine CHLO 66235

Cholesterol CHOL 66331

Cholesterol—HDL HDLC 66317

Cholinesterase CHSE 66367

Chorionic gonadotrophin—for pregnancy diagnosis HCG 73527

Chorionic gonadotrophin—for diagnosis of specified conditionsHCGD 73529

Chorionic gonadotrophin—for Down syndrome/neural tube defect testing NTDD 66321

Chromium CR 66277

Chromosome identification and banding  73287-89

Chromosome identification—studies—blood CSB 73289

Chromosome identification—studies—other than blood CS 73287

Cimetidine CMTD 66235

Clobazam CLOB 66235

Clomipramine CLOM 66235

Clonazepam (Rivotril) CLON 66235

Clostridium difficile—microbial antigen testing CLDT 69219

Coagulation—factors (see individual factors)

Coagulation—studies (see group tests) COAG 65035

Coagulation—time CT 65029

Coccidioides—microbial antibody testing CCC 69229

Cold agglutinins CAG 65005, 65027

Collection of specimen(s) for cytological examination  73051

Compatibility testing XMAT 65023

Complement, total haemolytic COM 71081

Complement, total haemolytic—components C3 C3 71083

Complement, total haemolytic—components C4 C4 71083

Complement, total haemolytic—properdin factor B PFB 71083

Complement, total haemolytic—other components COMP 71089

Copper CU 66277

Cortisol CORT 66391

Coxsackie B1‑6—microbial antibody testing COX 69229

Creatine kinase CK 66201

Creatine kinase—isoenzymes CKI 66201

Creatine kinase—isoenzymes (electrophoresis) CKIE 66245

Creatinine C 66201

Cryofibrinogen—qualitative CFID 66213

Cryofibrinogen—quantitative CFIE 66215

Cryoglobulins—qualitative CGLD 66213

Cryoglobulins—quantitative CGLE 66215

Cryoglobulins—investigation by immunoelectrophoresis or  immunofixationRYO 71061

Cryptococcal antigen—microbial antigen testing CRYN 69219

Cryptococcus—microbial antibody testing CRY 69229

CSF—microscopy and culture of material from MCS3 69209

CSF antigens—group B streptococcus STB 69219

CSF antigens—Haemophilus influenzae HI 69219

CSF antigens—Neisseria meningitidis NMG 69219

CSF antigens—Streptoccus pneumoniae SPN 69219

Cultural examination of faeces FCS 69211

Cyclic AMP CAMP 66391

Cyclosporin A CLSA 66235

Cystine—qualitative UCYS 66213

Cystine—quantitative CYST 66367

Cytology—from body fluids, sputum (1 specimen), urine, washings or brushingsBFCY 73045

Cytology—from cervix‑ routine CCR 73053

Cytology—from cervix—abnormalities CCRA 73055

Cytology—from fine needle aspiration of solid tissues FNCY 73049

Cytology—from fine needle aspiration of solid tissues—asp. or  attendance by a pathologist FNCP              73051

Cytology—from skin, nipple discharge, lip, mouth, nose or anusSMCY 73043

Cytology—from vagina CVO 73057

Cytology—from 3 sputum or urine specimens SPCY 73047

Cytomegalovirus—microbial antibody testing CMV 69229

Cytomegalovirus serology in pregnancy—microbial antibody testing CMVP 69253‑57

D‑dimer test DD 65029

D vitamin VITD 66271

Dehydroepiandrosterone sulphate (DHEAS) DHEA 66377

Dengue—microbial antibody testing DEN 69229

11-Deoxycortisol DCOR 66391

Desipramine DESI 66235

Dexamethasone DXST 66295

Dexamethasone—suppression test DEXA 66295

DHEAS (Dehydroepiandrosterone sulphate) DHEA 66377

Diazepam DIAZ 66235

Differential cell count DIFF 65005

Digoxin DIG 66235

Dihydrotesterone DHTS 66377

Diphenylhydantoin (Dilantin) DIL 66235

Diphtheria—microbial antibody testing DIP 69229

Direct Coombs test CMBS 65005, 65027

Disopyramide (Rythmodan) DISO 66235

DNA, double‑stranded antibodies DNAD 71099

DNA binding—quantitation and measurement if positive ANAANAP 71099

Down syndrome/neural tube defects NTDD 66321

Doxepin hydrochloride DOXE 66235

Drugs—abuse treatment programme—assay DATP 66343

Drugs—inappropriate dosage—assay DRGO 66231

Drugs—therapeutic—assay (See individual drugs)  66235

(Drugs not listed must be written in full)

Dynamic function tests GHSE 66295

Ear- microscopy and culture of material from MCS1 69205

Echinococcus—microbial antibody testing ECC 69229

Echo‑coxsackie group—microbial antibody testingECH 69229

Electrolytes (see group tests) E 66207

Electron microscopy of biopsy material EM 72807

Electrophoresis, to demonstrate—creatine kinase isoenzymesCKIE 66245

Electrophoresis, to demonstrate—lactate dehydrogenase isoenzymes LDI 66245

Electrophoresis, to demonstrate—protein classes, or paraproteinEPP1 66245

Electrophoresis, to demonstrate—protein classes or presence and amount of paraprotein classes, concurrent collection              EPP2              66247

Elements (see individual elements)

Entamoeba histolytica—microbial antibody testing AMO 69229

Enzyme assays of solid tissue or tissues ENZS 66285

Epstein Barr virus—microbial antibody testing EBV 69229

Erythrocyte—assessment of haemolysis ERYH 65009

Erythrocyte—assessment of metabolic enzymes ERYM 65009

Erythrocyte—count RCC 65001

Erythrocyte—sedimentation rate ESR 65001

Ethosuximide (Zarontin) ETHO 66235

Euglobulin clot lysis time ECLT 65037

Extractable nuclear antigens—detection of antibodies to ENA 71101

Eye—microscopy and culture of material from MCS1 69205

Factor II FII 65045

Factor V FV 65045

Factor VII FVII 65045

Factor VIII VIII 65045

Factor IX FIX 65045

Factor X FX 65045

Factor XI FXI 65045

Factor XII FXII 65045

Factor XIII XIII 65045

Factor XIII deficiency test F13D 65029

Faecal fat FFAT 66283

Faecal fat—haemoglobin—chemical test FHC 66217

Faecal fat—haemoglobin—immunological test FHI 66219

Faecal fat—porphyrins—qualitative test FPR 66217

Faecal fat—reducing substances FRS 66217

Faeces—cultural examination FCS 69211

Faeces—microscopic examination for parasites OCP 69203

Fatty acids—total free—estimation TFFA 60637

Ferritin (see also Iron studies) FERR 66355

Fibrin monomer FM 65029

Fibrinogen FIB 65029

Fibrinogen—degradation products FDP 65029

Fitzgerald factor FGF 65045

Flecainide FLEC 66235

Fletcher factor FF 65045

Fluorescent treponemal antibody—absorption test (FTA‑ABS)—microbial antibody testing FTA              69229

Fluoxetine FLUX 66235

Folate—red cell RCF 66267

Follicle stimulating hormone (FSH) FSH 66377

Frozen section diagnosis of biopsy material FS 72803

Fructosamine FRUC 66201

Full blood examination FBE 65007

Gamma glutamyl transpeptidase GGT 66201

Gastric parietal cell—tissue antigens—antibodies PCA 71119

Gastrin GAST 66391

Gliadin IgA—tissue antigens—antibodies GLIA 71119

Globulin GLOB 66201

Glomerular basement membrane—tissue antigens—antibodiesGBA 71109

Glucagon GLGO 66391

Glucagon stimulation test GSTC 66297

Glucose GLUC 66201

Glucose—tolerance test GTT 66201

Glycolated haemoglobin (Hb Alc) GHB 66319

Gold AU 66277

Gonadotrophin GRHS 66297

Group B streptococcus—CSF antigens STB 69219

Group B streptococcus—microbial antigen testing STB 69219

Group P9—simple basic pathology tests  73801‑11

Growth hormone GH 66391

Growth hormone—stimulation by exercise or L‑dopaGHSE 66295

Growth hormone—suppression by dexamethasone or glucoseGHSG 66295

Haematocrit HCT 65001

Haemoglobin estimation HB 65001

Haemoglobin estimation—in urine UHB 66213

Haemoglobinopathy tests HMGP 65011

Haemophilus influenzae antigens HI 69219

Haemophilus influenzae—microbial antibody testing HUS 69229

Haemophilus influenzae—microbial antigen testing HI 69219

Haloperidol HALO 66235

Haptoglobins HGLB 66361

HDL cholesterol HDLC 66317

Heart—tissue antigens—antibodies AHE 71109

Heparin—cofactor II HRNC 65037

Heparin—estimation HEPR 65043

Hepatitis delta antibody—anti‑delta—microbial antibody testing HDA 69229

Hepatitis serology—acute hepatitis HEP 69247

Hepatitis serology—follow‑up of proven hepatitis BHEPB 69249

Hepatitis serology—hepatitis B serology to define immune status HEP1 69245

Hepatitis serology—hepatitis B surface antigen HBsAg HBSA 69243

Hepatitis serology—hepatitis C HEPC 69265

Hepatitis serology—hepatitis delta antibody HDA 69229

Hepatitis serology—in pregnancy HEPP 69253‑57

Herpes simplex virus—direct detection from clinical materialHSV 69223

Herpes simplex virus—investigation by cultural methods HSVC 69263

Herpes simplex virus—microbial antibody testing HPA 69229

Herpes simplex virus—microbial antigen testing HSV 69223

Heterophile antibodies IM 65005, 65027

HIAA (hydroxyindoleacetic acid) HIAA 66367

Histamine HIAM 66367

Histone—tissue antigens—antibodies AHI 71109

Histopathology of biopsy material HIST 72801

Histoplasma—microbial antibody testing HIP 69229

HLA typing—HLA‑B27 HLAB 71147

HLA typing—HLA class 1 HLA1 71149

HLA typing—HLA class 2 HLA2 71151

HMMA (hydroxy‑3‑methoxymandelic acid previously known as VMA) HMMA              66281

HMPG (hydroxy methoxy phenylethylene glycol) HMPG 66281

Homovanillic acid HVA 66281

Hormone receptor assay—breast HRA 66315

Hormone receptor assay—ovary HRO 66315

Hormones—adrenocorticotrophic ACTH 66391

Hormones—aldosterone ALDS 66391

Hormones—androstanedione ANDR 66377

Hormones—C‑Peptide CPEP 66391

Hormones—calcitonin CALT 66391

Hormones—cortisol CORT 66391

Hormones—cyclic AMP CAMP 66391

Hormones—dehydroepiandrosterone sulphate DHEA 66377

Hormones—dihydrotestosterone DHTS 66377

Hormones—follicle stimulating hormone FSH 66377

Hormones—gastrin GAST 66391

Hormones—glucagon GLGO 66391

Hormones—gonadotrophin GRHS 66297

Hormones—growth hormone GH 66391

Hormones—growth hormone—stimulation by exercise or L‑dopa GHSE 66295

Hormones—growth hormone—suppression by dexamethasone or glucose GHSG 66295

Hormones—hormone receptor assay—breast HRA 66315

Hormones—hormone receptor assay—ovary HRO 66315

Hormones—human chorionic gonadotrophin—for pregnancy diagnosis HCG 73527

Hormones—human chorionic gonadotrophin—for diagnosis of specified conditions HCGD              73529

Hormones—human chorionic gonadotrophin—for Down syndrome/neural tube defect testing NTDD              66321

Hormones—human placental lactogen HPL 66373

Hormones—hydroxyprogesterone OHP 66377

Hormones—insulin INS 66391

Hormones—insulin, hypoglycaemia test INHY 66297

Hormones—luteinizing hormone LH 66377

Hormones—oestradiol E2 66377

Hormones—oestriol E3 66373

Hormones—oestrone E1 66377

Hormones—parathyroid hormone PTH 66391

Hormones—pentagastrin PSTR 66297

Hormones—progesterone PROG 66377

Hormones—prolactin PROL 66377

Hormones—renin REN 66391

Hormones—sex hormone binding globulin SHBG 66377

Hormones—somatomedin SOMA 66391

Hormones—testosterone TES 66377

Hormones—thyroid stimulating hormone (where not requested as part of TFTs)TSH 66371, 66377

Hormones—urine steroid fraction or fractions USF 66391

Hormones—vasoactive intestinal peptide VIP 66391

Hormones—vasopressin ADH 66391

Hormones—11 deoxycortisol DCOR 66391

Hormones and hormone binding proteins (See individual hormones and proteins)  66377, 66391

Huhner’s test HT 73521

Human chorionic gonadotrophin—for pregnancy diagnosis HCG 73527

Human chorionic gonadotrophin—for diagnosis of specified conditions HCGD 73529

Human chorionic gonadotrophin—for Down syndrome/neural tube defect testingNTDD 66321

Human placental lactogen HPL 66373

HVA (homovanillic acid) HVA 66281

Hydatid—microbial antibody testing HYD 69229

Hydroxy methoxy phenylethylene glycol HMPG 66281

Hydroxy‑3‑methoxymandelic acid previously known as VMA)HMMA 66281

Hydroxychloroquine HOCQ 66235

Hydroxyindoleacetic acid HIAA 66367

Hydroxyprogesterone OHP 66377

Hydroxyproline HYDP 66367

Imipramine IMIP 66235

Immediate frozen section diagnosis of biopsy material FS 72803

Immunoglobulins—A IGA 71067

Immunoglobulins—D IGD 71067

Immunoglobulins—E (total) IGE 71075‑79

Immunoglobulins—G IGG 71067

Immunoglobulins—G, 4 subclasses SIGG 71073

Immunoglobulins—M IGM 71067

Immunohistochemical investigation of biopsy material HIS 72805

Infectious mononucleosis IM 69229

Influenza A—microbial antibody testing FLA 69229

Influenza B—microbial antibody testing FLB 69229

Insulin INS 66391

Insulin—hypoglycaemia test INHY 66297

Insulin—tissue antigens—antibodies AINS 71109

Insulin receptor antibodies—tissue antigens—antibodies INSA 71109

Intercellular cement substance of skin—tissue antigens—antibodies ICCS 71109

Intestinal disaccharidases INTD 66283

Intrinsic factor—tissue antigens—antibodies AIF 71109

Iron studies (iron, transferrin and ferritin) IS 66263

Islet cell—tissue antigens—antibodies AIC 71109

Jo‑1—tissue antigens—antibodies JO1 71119

Keratin—tissue antigens—antibodies KERA 71119

L‑dopa GHLD 66295

Lactate LACT 66367

Lactate—dehydrogenase LDH 66201

Lactate—dehydrogenase isoenzymes LDI 66245

Lamellar body phospholipid LBPH 66243

Lead PB 66279

Lecithin/sphingomyelin ratio (amniotic fluid) LS 66243

Legionella pneumophila—serogroup 1—microbial antibody testing LP1 69229

Legionella pneumophila—serogroup 2—microbial antibody testing LP2 69229

Leishmaniasis—microbial antibody testing LEI 69229

Leptospira—microbial antibody testing LEP 69229

Leucocyte count WCC 65001

Leucocyte—3 surface markers—blood, CSF, serous fluid LMH3 71139

Leucocyte—3 surface markers—tissue LMT3 71141

Leucocyte—6 surface markers—blood, CSF, serous fluid or tissue LM6 71143

Leucocyte—6 surface markers—blood, CSF, serous fluid and tissue (s) LMHT 71145

Lignocaine LIGN 66235

Lip—cytology on specimens from SMCY 73043

Lipase LIP 66201

Lipid studies (see group tests) FATS 66331

Lipoprotein electrophoresis LEPG 66245

Listeria—microbial antibody testing LIS 69229

Lithium LI 66201

Liver function tests (see group tests) LFT 66211

Liver/kidney microsomes—tissue antigens—antibodies LKA 71119

Lupus anticoagulant LUPA 65037

Luteinising hormone LH 66377

Lymphocyte—tissue antigens—antibodies ALY 71109

Lymphocytes—functional tests—1 estimation LF1 71127

Lymphocytes—functional tests—2 estimations LF2 71129

Lymphocytes—functional tests—3 estimations LF3 71131

Magnesium MG 66201

Mammary serum antigen MSA 66261

Manganese MN 66277

Mantoux test MANT 73811

Measles—microbial antibody testing MEA 69229

Melanogen (see Urine melanin) UML 66213

Mercury HG 66277

Metalbumin detection (Schumm’s test) SCHM 65027

Metanephrines MNEP 66281

Methadone MTDN 66235

Methotrexate MTTA 66235

Methsuximide MSUX 66235

Metronidazole MRDZ 66235

Mexiletine (Mexitil) MEX 66235

Mianserin MIAS 66235

Microalbumin MALB 66361

Microbial antibody testing—actinomycetes ACT 69229

Microbial antibody testing—adenovirus ADE 69229

Microbial antibody testing—aspergillus ASP 69229

Microbial antibody testing—avian precipitins (bird fancier’s disease) APP 69229

Microbial antibody testing—Blastomyces BLM 69229

Microbial antibody testing—Bordetella pertussis BOR 69229

Microbial antibody testing—Borrelia burgdorferi BOB 69229

Microbial antibody testing—Brucella BRU 69229

Microbial antibody testing—Campylobacter jejuni CAM 69229

Microbial antibody testing—Candida CAN 69229

Microbial antibody testing—Chlamydia CHL 69229

Microbial antibody testing—Coccidioides CCC 69229

Microbial antibody testing—Coxsackie B1‑6 COX 69229

Microbial antibody testing—cryptococcus CRY 69229

Microbial antibody testing—cytomegalovirus CMV 69229

Microbial antibody testing—cytomegalovirus serology in pregnancy CMVP 69253‑57

Microbial antibody testing—dengue DEN 69229

Microbial antibody testing—diphtheria DIP 69229

Microbial antibody testing—echinococcus ECC 69299

Microbial antibody testing—echo‑coxsackie groupECH 69229

Microbial antibody testing—Entamoeba histolytica AMO 69229

Microbial antibody testing—Epstein Barr virus EBV 69229

Microbial antibody testing—fluorescent treponemal antibody—absorption test (FTA‑ABS) FTA              69229

Microbial antibody testing—Haemophilus influenzae HUS 69229

Microbial antibody testing—hepatitis C HEPC 69265

Microbial antibody testing—hepatitis delta antibody—anti‑delta HDA 69229

Microbial antibody testing—herpes HPA 69229

Microbial antibody testing—Histoplasma HIP 69229

Microbial antibody testing—hydatid HYD 69229

Microbial antibody testing—infectious mononucleosis IM 69229

Microbial antibody testing—influenza A FLA 69229

Microbial antibody testing—influenza B FLB 69229

Microbial antibody testing—Legionella pneumophila—serogroup 1 LP1 69229

Microbial antibody testing—Legionella pneumophila—serogroup 2 LP2 69229

Microbial antibody testing—leishmaniasis LEI 69229

Microbial antibody testing—Leptospira LEP 69229

Microbial antibody testing—Listeria LIS 69229

Microbial antibody testing—measles MEA 69229

Microbial antibody testing—Micropolyspora faeni MIC 69229

Microbial antibody testing—mumps MUM 69229

Microbial antibody testing—Murray Valley encephalitis MVE 69229

Microbial antibody testing—Mycoplasma pneumoniae MYC 69229

Microbial antibody testing—Neisseria menigitidis MEN 69229

Microbial antibody testing—Newcastle disease NCD 69229

Microbial antibody testing—parainfluenza 1 PF1 69229

Microbial antibody testing—parainfluenza 2 PF2 69229

Microbial antibody testing—parainfluenza 3 PF3 69229

Microbial antibody testing—paratyphi PTY 69229

Microbial antibody testing—pertussis PER 69229

Microbial antibody testing—poliomyelitis PLO 69229

Microbial antibody testing—Proteus OX 19 POX 69229

Microbial antibody testing—Proteus OXK POK 69229

Microbial antibody testing—Q fever QFF 69229

Microbial antibody testing—rapid plasma reagin test RPR 69229

Microbial antibody testing—respiratory syncytial virus RSV 69229

Microbial antibody testing—Ross River virus RRV 69229

Microbial antibody testing—rubella RUB 69229

Microbial antibody testing—Salmonella typhi (H) SAH 69229

Microbial antibody testing—Salmonella typhi (O) SAO 69229

Microbial antibody testing—Schistosoma STO 69229

Microbial antibody testing—streptococcal serology—anti‑DNASE B titre ADNB              69229

Microbial antibody testing—streptococcal serology—anti‑streptolysin O titre ASOT              69229

Microbial antibody testing—Streptococcus pneumoniae PCC 69229

Microbial antibody testing—tetanus TET 69229

Microbial antibody testing—Thermoactinomyces vulgaris THE 69229

Microbial antibody testing—thermopolyspora TPS 69229

Microbial antibody testing—Toxocara TOC 69229

Microbial antibody testing—toxoplasma TOX 69229

Microbial antibody testing—TPHA (Treponema pallidum haemagglutination test) TPHA              69229

Microbial antibody testing—Treponema pallidum haemagglutination test TPHA 69229

Microbial antibody testing—trichinosis TOS 69229

Microbial antibody testing—typhus, Weil‑Felix TYP 69229

Microbial antibody testing—Varicella zoster VCZ 69229

Microbial antibody testing—VDRL (Venereal Disease Research Laboratory)VDRL 69229

Microbial antibody testing—Yersinia enterocolitica YER 69229

Microbial antigen testing—Chlamydia CHLY 69221

Microbial antigen testing—Clostridium difficile CLDT 69219

Microbial antigen testing—group B streptococcus STB 69219

Microbial antigen testing—Haemophilus influenzae HI 69219

Microbial antigen testing—herpes simplex virus HSV 69263

Microbial antigen testing—Neisseria gonorrhoeae GON 69219

Microbial antigen testing—Neisseria meningitidis NMG 69219

Microbial antigen testing—respiratory syncytial virus RSVN 69219

Microbial antigen testing—Streptococcus pneumoniae SPN 69219

Microbial antigen testing—Varicella zoster VCZN 69219

Micropolyspora faeni MIC 69229

Microscopic examination of—faeces for parasites OCP 69203

Microscopic examination of—material other than blood M 69201

Microscopy and culture of—material from nose, throat, eye or ear MCS1 69205

Microscopy and culture of—material from skin, superficial sites, urethra, vagina, cervix or rectum  MCS2              69207

Microscopy and culture of—post‑op wounds, aspirations of body cavities, synovial fluid, CSF and op/biopsy specimens              MCS3              69209

Microscopy and culture of—specimens of sputum MCS2 69207

Microscopy and culture of—specimens of sputum, urine or other body fluids for mycobacteria AFB              69213

Microscopy, culture, identification and sensitivity of urineUMCS 69217

Mitochondria—tissue antigens—antibodies MA 71119

Mouth—cytology on specimens from SMCY 73043

Mucin‑like carcinoma associated antigen MCA1 66261

Mumps—microbial antibody testing MUM 69229

Murray Valley encephalitis- microbial antibody testing MVE 69229

Mycobacteria microscopy and culture of sputum AFB 69213

Mycoplasma pneumoniae—microbial antibody testing MYC 69229

Myoglobin in urine UMY 66213

N‑acetyl procainamide NAPC 66235

Neisseria gonorrhoeae—microbial antigen testing GON 69219

Neisseria menigitidis antigens NMG 69219

Neisseria menigitidis—microbial antibody testing MEN 69229

Neisseria menigitidis—microbial antigen testing NMG 69219

Neural tube defects/Down syndrome NTDD 66321

Neuron—tissue antigens—antibodies ANE 71109

Neuron specific enolase NSEN 66261

Neutrophil cytoplasm—tissue antigens—antibodies ANCA 71109

Neutrophil functions NFT 71135

Newcastle disease—microbial antibody testing NCD 69229

Nickel NI 66277

Nipple discharge—cytology on specimens from SMCY 73043

Nitrazepam NITR 66235

Nordothiepin NDIP 66235

Norfluoxetine NFLE 66235

Nortriptyline NORT 66235

Nose—cytology on specimens from SMCY 73043

Nose—microscopy and culture of material MCS1 69205

Nuclear antigens—detection of antibodies to ANA 71097

Oestradiol E2 66377

Oestriol E3 66373

Oestriol—for Down syndrome /neural tube defect testing NTDD 66321

Oestrone E1 66377

Oligoclonal proteins OGP 71065

Op/biopsy specimens—microscopy and culture of material fromMCS3 69209

Osmolality, serum or urine OSML 66223

Ovary—tissue antigens—antibodies AOV 71109

Oxalate OXAL 66367

Oxazepam OXAZ 66235

PAA (phenyl acetic acid) PAA 66281

Palmitic acid in amniotic fluid PALM 66243

Pap smear CCR 73053

Papanicolaou test CCR 73053

Paracetamol PARA 66235

Parainfluenza 1—microbial antibody testing PF1 69229

Parainfluenza 2—microbial antibody testing PF2 69229

Parainfluenza 3—microbial antibody testing PF3 69229

Paraprotein investigation—by electrophoresis EPPI 66245

Paraprotein investigation—by immunoelectrophoresis or immunofixation PPRO 71061

Paraprotein investigation—on concurrently collected serum or urine PPSU 71063

Paraquat PARQ 66235

Parasites—microscopic examination of faeces OCP 69203

Parathyroid hormone (PTH) PTH 66391

Parathyroid—tissue antigens—antibodies PTHA 71109

Paratyphi—microbial antibody testing PTY 69229

Partial thromboplastin time PTT 65029

Passovy factor PF 65045

Patient episode initiation fees PEI 73901‑15

Pentagastrin PSTR 66297

Pentobarbitone PENT 66235

Perhexiline PHEX 66235

Pertussis—microbial antibody testing PER 69229

pH measurement of body fluids other than urine PH 66213

Phenobarbitone PHBA 66235

Phensuximide PHEN 66235

Phenylacetic acid PAA 66281

Phenytoin PHEY 66235

Phosphate PHOS 66201

Phosphatidylglycerol PTGL 66243

Plasminogen PLAS 65037

Platelet—aggregation PLTG 65041

Platelet—count PLTC 65001

Platelet—tissue antigens—antibodies APA 71109

PM‑Sc1—tissue antigens—antibodies PM1 71119

Poliomyelitis—microbial antibody testing PLO 69229

Porphobilingen in urine UPG 66213

Porphyrins—quantitative test, 1 or more fractions PR 66281

Porphyrins in urine—qualitative test UPR 66213

Potassium K 66201

Prealbumin PALB 66361

Prednisolone PRED 66235

Pregnancy serology—1 estimation MSP1 69253

Pregnancy serology—2 estimations MSP2 69255

Pregnancy serology—3 estimations MSP3 69257

Pregnancy testing  73805

Pregnancy testing—diagnosis HCG 73527

Pregnancy testing—diagnosis of specified conditions HCGD 73529

Pregnancy testing—diagnosis for Down syndrome/neural tube defect NTDD 66321

Primidone PRIM 66235

Procainamide PCAM 66235

Progesterone PROG 66377

Prolactin PROL 66377

Prominal PROM 66235

Propranolol PPNO 66235

Prostate specific antigen PSA 66357

Prostatic acid phosphatase ACP 66357

Protein—C PROC 65037

Protein—S PROS 65037

Protein—quantitative estimation of—alpha fetoprotein AFP 66353

Protein—quantitative estimation of—alpha fetoprotein—for Down syndrome/neural tube defect testing NTDD              66321

Protein—quantitative estimation of—alpha‑l‑antitrypsin AAT 66255

Protein—quantitative estimation of—alpha‑2‑macroglobulinAMAC 66255

Protein—quantitative estimation of—beta‑2‑microglobulinBMIC 66361

Protein—quantitative estimation of—C‑l esterase inhibitor CEI 66257

Protein—quantitative estimation of—caeruloplasmin CPLS 66361

Protein—quantitative estimation of—classes by electrophoresisEPPI 66245

Protein—quantitative estimation of—ferritin (see also Iron studies) FERR 66355

Protein—quantitative estimation of—haptoglobins HGLB 66361

Protein—quantitative estimation of—microalbumin MALB 66361

Protein, total—quantitative estimation of PROT 66201

Proteus OX 19—microbial antibody testing POX 69229

Proteus OXK—microbial antibody testing POK 69229

Prothrombin time PT 65029

Pyruvate PVTE 66367

Q fever—microbial antibody testing QFF 69229

Quinalbarb QUIB 66235

Quinidine QUIN 66235

Quinine QNN 66235

Rapid plasma reagin test—microbial antibody testing RPR 69229

RAST RAST 71079

Rectum—microscopy and culture of material from MCS2 69207

Red cell folate and serum B12 and serum folate if required RCF 66267

Red cell porphyrins—qualitative test RCP 65027

Referred specimen fee  73921

Renin REN 66391

Respiratory syncytial virus—microbial antibody testing RSV 69229

Respiratory syncytial virus—microbial antigen testing RSVN 69219

Reticulin—tissue antigens—antibodies RCA 71119

Reticulocyte count RETC 65001

Rheumatoid factor RF 71105

Rheumatoid factor—quantitation RFQ 71107

Ross River virus—microbial antibody testing RRV 69229

RSV—respiratory syncytial virus—microbial antigen testingRSVN 69219

RSV—respiratory syncytial virus—microbial antibody testingRSV 69229

Rubella—serology RUB 69229

Salicylate—aspirin SALI 66235

Salivary gland—tissue antigens—antibodies ASG 71109

Salmonella typhi (H)—microbial antibody testing SAH 69229

Salmonella typhi (O)—microbial antibody testing SAO 69229

Schistosoma—microbial antibody testing STO 69229

Scl‑70—tissue antigens—antibodies SCL 71119

Secretin SSGR 66297

Selenium SE 66277

Semen examination SEE 73523

Semen examination—for spermatozoa (post vasectomy) SES 73521

Serology—in pregnancy (see Pregnancy serology)

Serotonin 5HT 66367

Serum—Bl2 B12 66265

Serum—folate (with Bl2) FOL 66265

Serum—folate (with Bl2 red cell folate) RCF 66267

Sex hormone binding globulin SHBG 66377

Skeletal muscle—tissue antigens—antibodies SLA 71109

Skin—cytology SMCY 73043

Skin—microscopy and culture of material from MCS2 69207

Skin basement membrane—tissue antigens—antibodies SKA 71109

Snake venom HISS 66231

Smooth muscle—tissue antigens—antibodies SMA 71119

Sodium NA 66201

Solid tissue or tissues—chemical assays ENZS 66285

Solid tissue or tissues—cytology of fine needle aspiration FNCY 73049

Solid tissue or tissues—cytology of fine needle aspiration by, or in presence of pathologist FNCP              73051

Somatomedin SOMA 66391

Sotalol SALL 66235

Specific IgG or IgE antibodies RAST 71079

Specimen referred fee  73921

Sperm antibodies SAB 73525

Sperm antibodies—penetrating ability SPA 73525

Sputum—cytology (1 specimen) BFCY 73045

Sputum—cytology (3 specimens) SPCY 73047

Sputum—microscopy and culture of specimens MCS2 69207

Sputum—for mycobacteria AFB 69213

Stelazine STEL 66235

Steroid fraction or fractions in urine USF 66391

Streptococcal serology—anti‑DNASE B titre—microbial antibody testing ADNB              69229

Streptococcal serology—anti‑streptolysin O titre—microbial antibody testing ASOT              69229

Streptococcus—Group B STB 69219

Streptococcus pneumoniae—antigens SPN 69219

Streptococcus pneumoniae—microbial antibody testing PCC 69229

Streptococcus pneumoniae—microbial antigen testing SPN 69219

Strontium SR 66277

Sulthiame (Ospolot) SUL 66235

Synacthen stimulation test SYNS 66297

Syphilis serology (see group tests) STS 69231

Testosterone TES 66377

Tetanus—microbial antibody testing TET 69229

Thalassaemia studies TS 65011

Theophylline THEO 66235

(Therapeutic drugs must be written in full)

Thermoactinomyces vulgaris—microbial antibody testing THE 69229

Thermopolyspora—microbial antibody testing TPS 69229

Thiopentone TOPO 66235

Thioridazine THIO 66235

Throat—microscopy and culture of material from MCS1 69205

Thrombin time TT 65029

Thyroglobulin TGL 66261

Thyroglobulin—tissue antigens—antibodies ATG 71109

Thyroid—function tests TFT 66291

Thyroid—stimulating hormone (where not requested as part of TFTs) TSH 66371, 66377

Thyroid microsome—tissue antigens—antibodies TMA 71109

Thyrotrophin releasing hormone test TRH 66293

(Tissue antigens which are not listed must be written in full)

Total free fatty acids TFFA 66367

Total protein PROT 66201

Toxocara—microbial antibody testing TOC 69229

Toxoplasma—microbial antibody testing TOX 69229

TPHA (Treponema pallidum haemagglutination test)—microbial antibody testingTPHA 69229

Treponema pallidum haemagglutination test—microbial antibody testing TPHA 69229

Trichinosis—microbial antibody testing TOS 69229

Triglycerides TRIG 66331

Trimipramine TRIM 66235